QMS Medi Approves Scheme of Arrangement, Merger Cooperation, and Acquisition of BeamOptics
QMS Medical Allied Services Limited approved a composite scheme of arrangement to demerge its healthcare services business into Saarathi Healthcare Private Limited. The company also signed an MOU to acquire 100% of BeamOptics Scientific Private Limited, with consideration based on a valuation report. The demerged QMS healthcare business had a turnover of ₹37.17 Crore in FY2026.
The composite scheme of arrangement involving multiple entities and the acquisition of another company represent substantial corporate actions that will likely have a significant impact on the company's structure, operations, and future growth prospects.
The company announced a significant restructuring and acquisition, which are generally positive developments aimed at business growth and synergy creation.
QMS Medical Allied Services Limited announced a significant composite scheme of arrangement involving QMS Medical Allied Services Limited, Health Care at Home India Private Limited, and Saarathi Healthcare Private Limited. The scheme aims to demerge the healthcare services business of QMS and HCAH into Saarathi Healthcare Private Limited, creating a combined entity focused on patient support programs and disease management. The turnover of the demerged undertaking of QMS for the financial year ended March 31, 2026, was ₹37.17 Crores, representing 24.41% of the total turnover.
The Board of Directors also approved the execution of a merger co-operation agreement and a shareholders' agreement among various parties, including QMS, its promoters, and other investment entities. These agreements will govern the implementation of the scheme and the relationships within the combined entity.
Furthermore, QMS Medical Allied Services Limited has entered into a binding Memorandum of Understanding (MOU) to acquire 100% of the equity shares of BeamOptics Scientific Private Limited. The consideration for this acquisition will be determined based on a valuation report from an independent valuer. BeamOptics Scientific Private Limited specializes in advanced optics, diagnostics, and analytical instruments for healthcare and other sectors, and had a turnover of ₹113.81 Lakhs in FY2026. This acquisition is expected to expand QMS Medical Allied Services Limited's total addressable market in the value-added healthcare business.
The Board meeting commenced at 3:15 PM IST and concluded at 3:50 PM IST on September 25, 2026.
What to do with a filing like this
QMS Medical Allied Services Limited filed this with the NSE as a statutory disclosure, categorised under merger. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by QMS Medical Allied Services Limited. Read the original for the full detail.